{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:00Z","timestamp":1793741040802,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.phrs.2022.106621","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:41:47Z","timestamp":1671190907000},"page":"106621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation"],"prefix":"10.1016","volume":"187","author":[{"given":"Mengyao","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueru","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106621_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155264","article-title":"Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: an overview and current perspectives","volume":"134","author":"Yan","year":"2022","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106621_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106621_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2022.106621_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.phrs.2022.106621_bib7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharm. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2022.106621_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106621_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106621_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.phrs.2022.106621_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908011","article-title":"The role of gut microbiota-bile acids axis in the progression of non-alcoholic fatty liver disease","volume":"13","author":"Ni","year":"2022","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031899","article-title":"Proglumide reverses nonalcoholic steatohepatitis by interaction with the farnesoid X receptor and altering the microbiome","volume":"23","author":"Gay","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2022.106621_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072135","article-title":"Perinatal high-salt diet induces gut microbiota dysbiosis, bile acid homeostasis disbalance, and NAFLD in weanling mice offspring","volume":"13","author":"Guo","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.phrs.2022.106621_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101160","article-title":"Diosgenin-rich yam extract enhances cognitive function: a placebo-controlled, randomized, double-blind, crossover study of healthy adults","volume":"9","author":"Tohda","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2022.106621_bib15","article-title":"Diosgenin from dioscorea nipponica rhizoma against graves' disease-on network pharmacology and experimental evaluation","volume":"12","author":"Xin","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2022.106621_bib16","article-title":"Diosgenin ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and related lipid\/amino acid metabolism in high fat diet-fed rats","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.sjbs.2020.11.045","article-title":"Regulatory effect of diosgenin on lipogenic genes expression in high-fat diet-induced obesity in mice","volume":"28","author":"Khateeb","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.510280118","article-title":"Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat","volume":"28","author":"Accatino","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.20540","article-title":"Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8","volume":"41","author":"Kosters","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1080\/01480545.2020.1814803","article-title":"Diosgenin inhibits TGF-beta1\/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis","volume":"45","author":"Dinesh Babu","year":"2022","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.phrs.2022.106621_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109885","article-title":"Diosgenin inhibits ER stress-induced inflammation in aorta via iRhom2\/TACE mediated signaling in experimental diabetic rats: an in vivo and in silico approach","volume":"358","author":"Prasad","year":"2022","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.phrs.2022.106621_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115311","article-title":"Q-marker identification of Paris polyphylla var. yunnanensis (Franch.) Hand.-Mazz. in pulmonary metastasis of liver cancer mice","volume":"293","author":"Wang","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106621_bib23","first-page":"1089","article-title":"Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways","volume":"41","author":"Cheng","year":"2018","journal-title":"Int J. Mol. Med"},{"issue":"4","key":"10.1016\/j.phrs.2022.106621_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01155-21","article-title":"Ileal bile acid transporter inhibitor improves hepatic steatosis by ameliorating gut microbiota dysbiosis in NAFLD model mice","volume":"12","author":"Matsui","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.phrs.2022.106621_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.629272","article-title":"Pharmacokinetic profile and oral bioavailability of diosgenin, charantin, and hydroxychalcone from a polyherbal formulation","volume":"12","author":"Salunkhe","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","article-title":"Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARalpha to activate the NF-kappaB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance","volume":"40","author":"Kong","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib27","doi-asserted-by":"crossref","first-page":"eaax6208","DOI":"10.1126\/sciadv.aax6208","article-title":"Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.phrs.2022.106621_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106621_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0029665120006916","article-title":"SCFA: mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc. Nutr. Soc."},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.phrs.2022.106621_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106621_bib33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbalip.2019.04.010","article-title":"Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8","volume":"1864","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.phrs.2022.106621_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104243","article-title":"Protective effect of diosgenin on LPS\/D-Gal-induced acute liver failure in C57BL\/6 mice","volume":"146","author":"Mohamadi-Zarch","year":"2020","journal-title":"Micro Pathog."},{"key":"10.1016\/j.phrs.2022.106621_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lfs.2018.01.012","article-title":"Atherogenic diet induced lipid accumulation induced NFkappaB level in heart, liver and brain of Wistar rat and diosgenin as an anti-inflammatory agent","volume":"196","author":"Binesh","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.phrs.2022.106621_bib38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jhep.2014.06.025","article-title":"Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease","volume":"61","author":"Pereira-Fantini","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI130976","article-title":"A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Zhao","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"13","key":"10.1016\/j.phrs.2022.106621_bib40","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1021\/acs.jafc.0c07467","article-title":"Gut microbiota and its metabolite deoxycholic acid contribute to sucralose consumption-induced nonalcoholic fatty liver disease","volume":"69","author":"Shi","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2022.106621_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol. Asp. Med"},{"key":"10.1016\/j.phrs.2022.106621_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.711055","article-title":"Procedures for fecal microbiota transplantation in murine microbiome studies","volume":"11","author":"Bokoliya","year":"2021","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.phrs.2022.106621_bib43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","article-title":"Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.phrs.2022.106621_bib45","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"7813","key":"10.1016\/j.phrs.2022.106621_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib47","doi-asserted-by":"crossref","first-page":"1949095","DOI":"10.1080\/19490976.2021.1949095","article-title":"Effect of different bile acids on the intestine through enterohepatic circulation based on FXR","volume":"13","author":"Xiang","year":"2021","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI133117","article-title":"Chronic diarrhea, bile acids, and Clostridia","volume":"130","author":"Walters","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.phrs.2022.106621_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","article-title":"Targeting the alternative bile acid synthetic pathway for metabolic diseases","volume":"12","author":"Jia","year":"2021","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.phrs.2022.106621_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.phrs.2022.106621_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res"},{"issue":"5","key":"10.1016\/j.phrs.2022.106621_bib52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/14728222.2014.997711","article-title":"Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target","volume":"19","author":"Liu","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.phrs.2022.106621_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41374-020-00509-x","article-title":"Stress can attenuate hepatic lipid accumulation via elevation of hepatic beta-muricholic acid levels in mice with nonalcoholic steatohepatitis","volume":"101","author":"Takada","year":"2021","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.phrs.2022.106621_bib54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00394-020-02431-w","article-title":"A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier","volume":"60","author":"Liu","year":"2021","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"10.1016\/j.phrs.2022.106621_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13543784.2020.1763302","article-title":"Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Fiorucci","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2022.106621_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/j.2040-4603.2020.tb00108.x","article-title":"Intestinal absorption of bile acids in health and disease","volume":"10","author":"Ticho","year":"2019","journal-title":"Compr. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106621_bib57","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Review article: therapeutic aspects of bile acid signalling in the gut-liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment Pharm. Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:58Z","timestamp":1760913838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822005679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":57,"alternative-id":["S1043661822005679"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106621","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106621"}}